Progress and remaining challenges for cancer control in Latin America and the Caribbean

Kathrin Strasser-Weippl; Yanin Chavarri-Guerra; Cynthia Villarreal-Garza; Brittany L. Bychkovsky; Marcio Debiasi; Pedro E.R. Liedke; Enrique Soto-Perez-de-Celis; Don Dizon; Eduardo Cazap; Gilberto de Lima Lopes; Diego Touya; Joao Soares Nunes; Jessica Louis; Caroline Vail; Alexandra Bukowski; Pier Ramos-Elias; Karla Unger-Saldaña; Denise Froes Brandao; Mayra E. Ferreyra; Silvana Luciani; Angelica Nogueira-Rodrigues; Aknar Freire de Carvalho Calabrich; Marcela G. Del Carmen; Jose Alejandro Rauh-Hain; Kathleen Schmeler; Raúl Sala; Paul E. Goss

doi:10.1016/S1470-2045(15)00218-1

Progress and remaining challenges for cancer control in Latin America and the Caribbean

Kathrin Strasser-Weippl, Yanin Chavarri-Guerra, Cynthia Villarreal-Garza, Brittany L. Bychkovsky, Marcio Debiasi, Pedro E.R. Liedke, Enrique Soto-Perez-de-Celis, Don Dizon, Eduardo Cazap, Gilberto de Lima Lopes, Diego Touya, Joao Soares Nunes, Jessica Louis, Caroline Vail, Alexandra Bukowski, Pier Ramos-Elias, Karla Unger-Saldaña, Denise Froes Brandao, Mayra E. Ferreyra, Silvana LucianiAngelica Nogueira-Rodrigues, Aknar Freire de Carvalho Calabrich, Marcela G. Del Carmen, Jose Alejandro Rauh-Hain, Kathleen Schmeler, Raúl Sala, Paul E. Goss

School of Medicine

Research output: Contribution to journal › Review article › peer-review

87 Scopus citations

Abstract

Cancer is one of the leading causes of mortality worldwide, and an increasing threat in low-income and middle-income countries. Our findings in the 2013 Commission in The Lancet Oncology showed several discrepancies between the cancer landscape in Latin America and more developed countries. We reported that funding for health care was a small percentage of national gross domestic product and the percentage of health-care funds diverted to cancer care was even lower. Funds, insurance coverage, doctors, health-care workers, resources, and equipment were also very inequitably distributed between and within countries. We reported that a scarcity of cancer registries hampered the design of credible cancer plans, including initiatives for primary prevention. When we were commissioned by The Lancet Oncology to write an update to our report, we were sceptical that we would uncover much change. To our surprise and gratification much progress has been made in this short time. We are pleased to highlight structural reforms in health-care systems, new programmes for disenfranchised populations, expansion of cancer registries and cancer plans, and implementation of policies to improve primary cancer prevention.

Original language	English (US)
Pages (from-to)	1405-1438
Number of pages	34
Journal	The Lancet Oncology
Volume	16
Issue number	14
DOIs	https://doi.org/10.1016/S1470-2045(15)00218-1
State	Published - Oct 2015

ASJC Scopus subject areas

Oncology

Access to Document

10.1016/S1470-2045(15)00218-1

Cite this

Strasser-Weippl, K., Chavarri-Guerra, Y., Villarreal-Garza, C., Bychkovsky, B. L., Debiasi, M., Liedke, P. E. R., Soto-Perez-de-Celis, E., Dizon, D., Cazap, E., de Lima Lopes, G., Touya, D., Nunes, J. S., Louis, J., Vail, C., Bukowski, A., Ramos-Elias, P., Unger-Saldaña, K., Brandao, D. F., Ferreyra, M. E., ... Goss, P. E. (2015). Progress and remaining challenges for cancer control in Latin America and the Caribbean. The Lancet Oncology, 16(14), 1405-1438. https://doi.org/10.1016/S1470-2045(15)00218-1

Strasser-Weippl, K, Chavarri-Guerra, Y, Villarreal-Garza, C, Bychkovsky, BL, Debiasi, M, Liedke, PER, Soto-Perez-de-Celis, E, Dizon, D, Cazap, E, de Lima Lopes, G, Touya, D, Nunes, JS, Louis, J, Vail, C, Bukowski, A, Ramos-Elias, P, Unger-Saldaña, K, Brandao, DF, Ferreyra, ME, Luciani, S, Nogueira-Rodrigues, A, de Carvalho Calabrich, AF, Del Carmen, MG, Rauh-Hain, JA, Schmeler, K, Sala, R & Goss, PE 2015, 'Progress and remaining challenges for cancer control in Latin America and the Caribbean', The Lancet Oncology, vol. 16, no. 14, pp. 1405-1438. https://doi.org/10.1016/S1470-2045(15)00218-1

@article{d5ee5a8a56aa4aa5916934e7758e6a6b,

title = "Progress and remaining challenges for cancer control in Latin America and the Caribbean",

abstract = "Cancer is one of the leading causes of mortality worldwide, and an increasing threat in low-income and middle-income countries. Our findings in the 2013 Commission in The Lancet Oncology showed several discrepancies between the cancer landscape in Latin America and more developed countries. We reported that funding for health care was a small percentage of national gross domestic product and the percentage of health-care funds diverted to cancer care was even lower. Funds, insurance coverage, doctors, health-care workers, resources, and equipment were also very inequitably distributed between and within countries. We reported that a scarcity of cancer registries hampered the design of credible cancer plans, including initiatives for primary prevention. When we were commissioned by The Lancet Oncology to write an update to our report, we were sceptical that we would uncover much change. To our surprise and gratification much progress has been made in this short time. We are pleased to highlight structural reforms in health-care systems, new programmes for disenfranchised populations, expansion of cancer registries and cancer plans, and implementation of policies to improve primary cancer prevention.",

author = "Kathrin Strasser-Weippl and Yanin Chavarri-Guerra and Cynthia Villarreal-Garza and Bychkovsky, {Brittany L.} and Marcio Debiasi and Liedke, {Pedro E.R.} and Enrique Soto-Perez-de-Celis and Don Dizon and Eduardo Cazap and {de Lima Lopes}, Gilberto and Diego Touya and Nunes, {Joao Soares} and Jessica Louis and Caroline Vail and Alexandra Bukowski and Pier Ramos-Elias and Karla Unger-Salda{\~n}a and Brandao, {Denise Froes} and Ferreyra, {Mayra E.} and Silvana Luciani and Angelica Nogueira-Rodrigues and {de Carvalho Calabrich}, {Aknar Freire} and {Del Carmen}, {Marcela G.} and Rauh-Hain, {Jose Alejandro} and Kathleen Schmeler and Ra{\'u}l Sala and Goss, {Paul E.}",

note = "Funding Information: EC received personal fees from Bayer Bristol-Myers Squibb, Fresenius, and Roche outside the submitted work. GdLL received grants and personal fees from Merck Serono; Merck, Sharp and Dohme; Roche/Genentech, Bristol-Myers Squibb, Boehringer Ingelheim, and Novartis, outside the submitted work. GdLL received personal fees from Sanofi Aventis, outside the submitted work. PERL received research funding from Novartis, Roche, and Medivation, outside the submitted work. All other authors declare no competing interests. Funding Information: PEG, JSL, AB, and DFB are supported by the Avon Foundation, New York, NY, USA. Publisher Copyright: {\textcopyright} 2015 Elsevier Ltd.",

year = "2015",

month = oct,

doi = "10.1016/S1470-2045(15)00218-1",

language = "English (US)",

volume = "16",

pages = "1405--1438",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "14",

}

TY - JOUR

T1 - Progress and remaining challenges for cancer control in Latin America and the Caribbean

AU - Strasser-Weippl, Kathrin

AU - Chavarri-Guerra, Yanin

AU - Villarreal-Garza, Cynthia

AU - Bychkovsky, Brittany L.

AU - Debiasi, Marcio

AU - Liedke, Pedro E.R.

AU - Soto-Perez-de-Celis, Enrique

AU - Dizon, Don

AU - Cazap, Eduardo

AU - de Lima Lopes, Gilberto

AU - Touya, Diego

AU - Nunes, Joao Soares

AU - Louis, Jessica

AU - Vail, Caroline

AU - Bukowski, Alexandra

AU - Ramos-Elias, Pier

AU - Unger-Saldaña, Karla

AU - Brandao, Denise Froes

AU - Ferreyra, Mayra E.

AU - Luciani, Silvana

AU - Nogueira-Rodrigues, Angelica

AU - de Carvalho Calabrich, Aknar Freire

AU - Del Carmen, Marcela G.

AU - Rauh-Hain, Jose Alejandro

AU - Schmeler, Kathleen

AU - Sala, Raúl

AU - Goss, Paul E.

N1 - Funding Information: EC received personal fees from Bayer Bristol-Myers Squibb, Fresenius, and Roche outside the submitted work. GdLL received grants and personal fees from Merck Serono; Merck, Sharp and Dohme; Roche/Genentech, Bristol-Myers Squibb, Boehringer Ingelheim, and Novartis, outside the submitted work. GdLL received personal fees from Sanofi Aventis, outside the submitted work. PERL received research funding from Novartis, Roche, and Medivation, outside the submitted work. All other authors declare no competing interests. Funding Information: PEG, JSL, AB, and DFB are supported by the Avon Foundation, New York, NY, USA. Publisher Copyright: © 2015 Elsevier Ltd.

PY - 2015/10

Y1 - 2015/10

N2 - Cancer is one of the leading causes of mortality worldwide, and an increasing threat in low-income and middle-income countries. Our findings in the 2013 Commission in The Lancet Oncology showed several discrepancies between the cancer landscape in Latin America and more developed countries. We reported that funding for health care was a small percentage of national gross domestic product and the percentage of health-care funds diverted to cancer care was even lower. Funds, insurance coverage, doctors, health-care workers, resources, and equipment were also very inequitably distributed between and within countries. We reported that a scarcity of cancer registries hampered the design of credible cancer plans, including initiatives for primary prevention. When we were commissioned by The Lancet Oncology to write an update to our report, we were sceptical that we would uncover much change. To our surprise and gratification much progress has been made in this short time. We are pleased to highlight structural reforms in health-care systems, new programmes for disenfranchised populations, expansion of cancer registries and cancer plans, and implementation of policies to improve primary cancer prevention.

AB - Cancer is one of the leading causes of mortality worldwide, and an increasing threat in low-income and middle-income countries. Our findings in the 2013 Commission in The Lancet Oncology showed several discrepancies between the cancer landscape in Latin America and more developed countries. We reported that funding for health care was a small percentage of national gross domestic product and the percentage of health-care funds diverted to cancer care was even lower. Funds, insurance coverage, doctors, health-care workers, resources, and equipment were also very inequitably distributed between and within countries. We reported that a scarcity of cancer registries hampered the design of credible cancer plans, including initiatives for primary prevention. When we were commissioned by The Lancet Oncology to write an update to our report, we were sceptical that we would uncover much change. To our surprise and gratification much progress has been made in this short time. We are pleased to highlight structural reforms in health-care systems, new programmes for disenfranchised populations, expansion of cancer registries and cancer plans, and implementation of policies to improve primary cancer prevention.

UR - http://www.scopus.com/inward/record.url?scp=84945935807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945935807&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(15)00218-1

DO - 10.1016/S1470-2045(15)00218-1

M3 - Review article

C2 - 26522157

AN - SCOPUS:84945935807

SN - 1470-2045

VL - 16

SP - 1405

EP - 1438

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 14

ER -

Progress and remaining challenges for cancer control in Latin America and the Caribbean

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this